Introduction {#Sec1}
============

Cyanophycin or cyanophycin granule peptide (CGP) was first discovered in 1887 by Borzi while examining cyanobacteria with a microscope (Borzi [@CR5]). Later, it was discovered that all groups of cyanobacteria produce CGP (Oppermann-Sanio and Steinbuchel [@CR27]) as well as many heterotrophic bacteria (Krehenbrink et al. [@CR19]). CGP is a polypeptide that results from non-ribosomal protein synthesis by a single enzyme, cyanophycin synthetase (CphA) (Ziegler et al. [@CR45]). The molecule consists of an α-amino-α-carboxy linked aspartic acid backbone to which arginine residues are linked to the β-carboxyl group of each aspartic acid (Simon and Weathers [@CR35]) (Fig. [1](#Fig1){ref-type="fig"}). The non-ribosomal synthesis results in a polydisperse size distribution. In addition, the molecular mass depends on the CGP producing organism (Krehenbrink et al. [@CR19]); in cyanobacteria, the molecular mass ranges from 25 to 100 kDa (Hai et al. [@CR16]; Lang et al. [@CR22]; Simon [@CR33], [@CR34]). At neutral pH and under physiological ionic strength, CGP is in general water insoluble, although a CGP form was described that is water soluble at neutral pH (Ziegler et al. [@CR44]). The water-insoluble CGP can become water soluble at extreme pH values (below 3 or above 9) or under high ionic strength (Fuser and Steinbuchel [@CR13]; Simon [@CR33]).Fig. 1Schematic overview of a CGP molecule. Schematic representation of a CGP molecule with an aspartic acid backbone and arginine side chains (Simon and Weathers [@CR35])

CGP has potentially many industrial applications, it can be used for the production of poly([l]{.smallcaps}-aspartic acid) (PAA) generated by β-cleavage of the side chains. PAA can be used as substitute for non-degradable poly(anionic) molecules such as polyacrylic acid (Sanders et al. [@CR30]). CGP can also be applied for the production of anti-scalants, dispersing agents, or bulk chemicals such as acrylonitrile (Könst et al. [@CR17]), urea, and 1,4-butanediamine (Könst et al. [@CR18]; Schwamborn [@CR31]; Scott et al. [@CR32]).

Currently, the application of CGP is hampered by the lack of a cost-effective production process in cyanobacteria as a result of the low yield and strict growth requirements such as light and complex media. In order to increase the production efficiency, *cphA-*encoding genes from various biological sources were expressed in *Escherichia coli* (Berg et al. [@CR4]; Frey et al. [@CR12]; Krehenbrink et al. [@CR19]; Ziegler et al. [@CR44]; Ziegler et al. [@CR45]; Hai et al. [@CR16]; Aboulmagd et al. [@CR2]) and other commercially relevant bacteria such as *Corynebacterium glutamicum*, *Ralstonia eutropha*, and *Pseudomonas putida* (Aboulmagd et al. [@CR3]; Voss et al. [@CR39]; Diniz et al. [@CR10]). The maximal yield in these bacteria varied strongly with a maximum yield of 35% (*w*/*w*). In eukaryotic microorganisms like *Saccharomyces cerevisiae* (Bröker et al. [@CR6]) and *Pichia pastoris* (Bröker et al. [@CR7]), the maximal CGP yield dropped to 15% *w*/*w*).

Filamentous fungi of *Rhizopus oryzae* spp. have great potential in biotechnological applications. This is due to their ability to utilize a range of simple carbon substrates such as [d]{.smallcaps}-glucose, [d]{.smallcaps}-xylose, sucrose, and lactose (Vially et al. [@CR38]). Next to simple carbohydrates, *R. oryzae* spp. can also grow on agricultural waste streams (Abedinifar et al. [@CR1]; Bulut et al. [@CR8]; Guo et al. [@CR15]; Xu et al. [@CR40]; Yao et al. [@CR41]; Yen and Lee [@CR42]; Yu and Hang [@CR43]). Using these carbon sources, it can produce ethanol and organic acids like [l]{.smallcaps}-(+)-lactic, fumaric and [l]{.smallcaps}-(+)-malic acid (Lockwood et al. [@CR23]; Magnuson and Lasure [@CR24]). These organic acids have wide applications in the food and feed industry. In addition, these compounds can be applied as feedstock in order to produce renewable resources like plastics, fibers, solvents, and oxygenated chemicals (Datta and Henry [@CR9]; Engel et al. [@CR11]; Goldberg et al. [@CR14]; Roshchin [@CR29]). The biotechnological potential of *R. oryzae* spp. further increased by the publication of the genome sequence of strain 99-880 in 2004 and with the development of transformation systems based on uracil auxotrophy (Skory and Ibrahim [@CR37]).

To investigate the potential for the production of CGP in a fungal expression system, we have expressed the *cphA-*encoding genes from *Synechocystis* sp. strain PCC6803, *Anabaena* sp. strain PCC7120 and its codon-optimized version in the auxotrophic mutant *R. oryzae* M16 derived from *R. oryzae* 99-880.

Materials and methods {#Sec2}
=====================

Strains, media, growth conditions, and methods {#Sec3}
----------------------------------------------

One Shot® Mach1™ T1 Phage-Resistant *E. coli* (Invitrogen Carlsbad, CA) was used for plasmid maintenance and propagation. The cells were grown in Luria-Bertani (LB) medium containing 50 μg/ml ampicillin or kanamycin at 37°C with agitation at 250 rpm. In this study, *R. oryzae* 99-880 (Fungal Genetics Stock Center FGSC 9543) for which the genome sequence is known and the from this strain-derived orotate phosphoribosyltransferase (*pyrF*) auxotrophic mutant M16 (Skory and Ibrahim [@CR37]) were used. The auxotrophic mutant M16 was a kind gift of Dr. C. D. Skory of the USDA, Peoria, IL. Spores were obtained by cultivation on synthetic *Rhizopus* (RZ) medium (Skory [@CR36]) containing 1.5% (*w*/*v*) agar and 2% [d]{.smallcaps}-glucose. For growth of *R. oryzae* M16, the medium was supplemented with 0.5 mg/ml uracil. The plates were incubated for 4 days at 30°C. The spores were harvested using a saline Tween-80 solution \[0.9% (*w*/*v*) NaCl, 0.005% (*v*/*v*) Tween-80\]. Details for the strains and plasmids are listed in Table [1](#Tab1){ref-type="table"}. All experiments were performed with biomass obtained from liquid cultures unless stated otherwise. Biomass of *R. oryzae* transformants and wild-type was generated by cultivation in shake flasks containing 100 ml RZ medium using 100 g/l of [D]{.smallcaps}-glucose as a carbon source, inoculated with 10^6^ spores per milliter. The cultures were incubated for 72 h at 30°C with constant agitation in an orbital shaker at 200 rpm. To maintain a stable pH, 10 g/l CaCO~3~ was added after 18 h. When the CaCO~3~ was almost dissipated, fresh CaCO~3~ was added.Table 1Strains and plasmids used in this study Ap^r^, ampicillin resistance, Km^r^, kanamycin resistance and Cm^r^, chloramphenicol resistanceStrain or plasmidDescriptionReference or source*E. coli* One Shot® Mach1™F-φ80 (lacZ) Δ*M15* Δ*lacX74* hsdR (rK-mK+) Δ*recA1398 endA1 tonA*(Invitrogen Carlsbad, CA)*R. oryzae* 99-880Sequenced strainFungal Genetics Stock Center FGSC 9543)*R. oryzae* M16Auxotrophic mutant derived from *R. oryzae* 99-880 Δ*pyrF*(Skory and Ibrahim [@CR37])pBBR1MCS-2::*cphA*~7120~Kmr, broad host range vector, lacPOZ\' harboring *cphA* from *Anabaena* sp. strain PCC7120 collinear to *lacPOZ\'*(Voss et al. [@CR39]) Gift of Prof. Dr. A. SteinbüchelpJet::*cphA*~7120~Ap^r^ harboring *cphA* from *Anabaena* sp. strain PCC7120This studypMa/c5-914::*cphA*~6803~Ap^r^ Cm^r^ c1857ts \_ PL/PR, translational initiation region harboring a 2.6-kb PCR product from *Synechocystis* sp. strain PCC6803(Frey et al. [@CR12]) Gift of Prof. Dr. A. SteinbüchelpJet::*cphA*~6803~Ap^r^ harboring a 2.6-kb PCR product from *Synechocystis* sp. strain PCC6803This studypPdcExPyrFAp^r^*pdcA* promoter and terminatorGift of Dr. C. D. SkorypPdcExPyrF::*cphA*~6803~pPdcExPyrF harboring a 2.6-kb PCR product from *Synechocystis* sp. strain PCC6803 cloned with *Sph*I and *Pac*IThis studypPdcExPyrF::*cphA*~7120~pPdcExPyrF harboring *cphA* from *Anabaena* sp. strain PCC7120 cloned with *Sph*I and *Pac*IThis study*cphA*~7120~ codon optimizedCodon optimized *cphA* from *Anabaena* sp. strain PCC7120DNA2.0, Menlo Park, CApPdcExPyrF::*cphA*~7120~ codon optimizedpPdcExPyrF harboring *cphA* from *Anabaena* sp. strain PCC7120 cloned with *Sph*I and *Pac*IThis study

DNA techniques {#Sec4}
--------------

The *cphA*~7120~ gene originating from *Anabaena* sp. strain PCC7120 was cloned from plasmid pBBR1MCS-2::*cphA*~7120~ (Voss et al. [@CR39]). The *cphA*~6803~ gene originating from *Synechocystis* sp. strain PCC6803 was cloned from plasmid pMa/c5-914::*cphA*~6803~ (Frey et al. [@CR12]). Both plasmids were a kind gift from Prof. Dr. A. Steinbüchel of the WWU Münster, Germany. The genes were cloned by PCR amplification using Phusion DNA polymerase (Finnzymes, Espoo, Finland). The oligonucleotide primers used for PCR amplification were 7120FS and 7120RS for *cphA*~7120~ and 6803FS and 6803RP for *cphA*~6803~ (Table [2](#Tab2){ref-type="table"}). The correct size of the DNA fragments was verified by agarose gel electrophoresis using 0.8% agarose with 0.5 times Tris--acetate--EDTA (TAE) buffer. The amplicons were ligated into the plasmid pJET1.2/blunt using the CloneJET™ PCR Cloning Kit (Fermentas International Inc, Burlington, Canada) according to the manufacturer\'s instructions. Codon-optimized versions of both genes were ordered from DNA 2.0 (Menlo Park, CA). Codon optimization was performed based on the codon table of Kazusa DNA Research Institute (Kisarazu, Japan). Electro transformation of *E. coli* was performed with the Gene pulser II using cuvettes with a 0.2-cm gap (Bio-Rad, Hercules, CA). Isolation of plasmid DNA was performed using a GeneJET^TM^ plasmid miniprep kit (Fermentas International Inc, Burlington, Canada) according to the manufacturer's instructions. The plasmid pJet::*cphA*~7120~ and pJet::*cphA*~6803~ were digested using the restriction enzymes *Sph*I and *Pac*I (New England Biolabs, Ipswich, MA), subsequently ligated into the *Sph*I and *Pac*I sites of plasmid pPdcExPyrF. Plasmid pPdcExPyrF was a kind gift of Dr. C. D. Skory of the USDA, Peoria, IL. The nucleotide sequences of all fragments were verified by DNA sequence analysis (Baseclear BV, Leiden, The Netherlands).Table 2Oligonucleotide primers used in this studyOligonucleotide primerOligonucleotide primer sequence 5′ to 3′ orientation7120FS**GCATGC**GAATCCTCAAGATCCAGACC7120RPGGGAATCACCACATCTCTACTA**TTAATTAA**AGCAAAGTA7120qFCTGGATGAAACCCAAGCAAT7120qRCGGTTGTCGAGGAATTTTGT6803FS**GCATGC**AAATTCTTAAAACCCTTACCCTCCGC6803RP**TTAATTAA**CCAATGGGTTTACGGGCTTT[G]{.ul}ATTAAC6803qFTCAATCTGGGTCGGTACCAT6803qRGGCCCCGTTTATCATCATCTkanqFAGCATTACGCTGACTTGACGkanqRAGGTGGACCAGTTGGTGATT7120coqFTTAAACCTGATGCCCGATATG7120coqRTGACCAAGCCTCTCAGTTTGPDCqFACAGCCGAATTTGCTTCACTPDCqRGATAGCGGCCCTACAGAGGCharacters in bold indicate the restriction sites that were introduced. The underlined character indicates the location of a silent mutation in order to remove an existing restriction site. Primer 7120RP is designed to have an overlap with the donor plasmid to facilitate cloning

Transformation of *R. oryzae* and stability assay of transformants {#Sec5}
------------------------------------------------------------------

Transformation of *R. oryzae* M16 spores was achieved by particle bombardment. M5 tungsten particles (Bio-Rad, Hercules, CA) were coated with plasmid DNA according to the manufacturer\'s instructions. The particles were delivered by the PDS-1000/He Biolistic Particle Delivery System (Bio-Rad, Hercules, CA), having a distance between the rupture disc and the particles of 1.6 cm. The distance between the particles and the spores was 6 cm. Spores (10^5^) of *R. oryzae* M16 were plated on RZ medium and bombarded. The pressure was set with a rupture disc at 1,100 psi. To allow the formation of biomass and spores, the plates were incubated at 30°C for 5 to 7 days. After sporulation, the spores were harvested, and serial dilutions were made that were used to inoculate RZ plates with one spore. This process was repeated to ensure single progeny. In order to determine the stability of the transformants, serial dilutions of the spores grown from the glycerol stocks were made ranging from 8 to 8 × 10^9^ spores per plate. The spores were plated on RZ medium containing 5-fluoroorotic acid (5-FOA) and 5-FOA complemented with 0.5 mg/ml uracil.

Transcript analysis {#Sec6}
-------------------

To determine the presence of *cphA* mRNA in the transformants, liquid cultures were grown as described in the previous section. Mycelium was harvested after 72 h, frozen in liquid nitrogen, and ground using a Braun micro-dismembrator (Braun, Melsungen, Germany). RNA was isolated and cDNA was generated as described by Oliveira et al. ([@CR26]). The cDNA served as the template for quantitative real-time PCR (qPCR). Primers were designed with the Primer3 program to have a specific melting temperature of 60 ± 1°C, GC content of 50 ± 5%, and amplicon sizes between 139 and 150 bp. The primers used were 7120qF, 7120qR, 7120coqF, 7120coqR 6803qF, and 6803qR. Two reference genes were used; as an external reference gene kanamycin, the primers were kanqF and kanqR (Table [2](#Tab2){ref-type="table"}) and as an internal reference gene pyruvate decarboxylase was used with the primers PDCqF and PDCqR (Table [2](#Tab2){ref-type="table"}). The PCR mixes were pipetted with the CAS-1200 robot (Corbett Life Science, Sydney, Australia). Reaction mixtures for real-time PCR had a total volume of 16 μl and contained 4 μl cDNA (2.5 ng/μl), 1.2 μl of each primer (1.2 μM), and 10 μl ABsolute QPCR SYBR Green Mix (ABgene, Epsom, UK). The Rotor-Gene 3000 (Corbett Life Science) was used for thermal cycling and real-time detection of the DNA. The melting analysis feature was used to determine primer--dimer formation, and the comparative quantitation feature was used to determine take-off and amplification values. Relative expression was calculated by the Pfaffl method (Pfaffl [@CR28]). Normalization was performed on the basis of the added kanamycin external transcript proportional to the total RNA used for cDNA synthesis. Additionally, normalization was performed on the basis of pyruvate decarboxylase (PDC).

Cyanophycin synthetase activity assay {#Sec7}
-------------------------------------

CphA activity was determined in cell-free extracts by a scintillation assay performed as described by Aboulmagd et al. ([@CR2]) using L-\[2,3,4,5-^3^H\] arginine monohydrochloride (GE Healthcare, Piscataway, NJ) with a specific activity of 1.59 TBq/mmol. The cell-free extract was obtained by centrifugation of a suspension of 100 mg grinded mycelium in 500 μl 20 mM Tris/HCl buffer pH 7.5 (4ºC, 16,100 g). To determine the effect of protease activity, 12.5 μl protease inhibitor cocktail (P8215) (Sigma-Aldrich, St. Louis, MO) was added to the cell-free extract. The activity was measured by adding the reaction mixture in a 1 to 10 ratio to Ultima gold scintillation liquid (Perkin-Elmer Life Sciences, Boston, MA) and scintillation counting in a model 1600 TR Tri-Carb liquid scintillation counter (Packard Instrument Company, Meriden, CT). To determine the specific activity, the protein concentrations in the cell-free extract were determined with a Bradford protein assay (Bio-Rad, Hercules, CA). The protein standards were prepared with bovine serum albumin. All experiments were performed in triplicate. The specific enzyme activity was expressed in units per milligram, which represents the incorporation rate of [l]{.smallcaps}-arginine in nanomoles per minute per milligram of total protein in the cell-free extract.

Isolation and analysis of cyanophycin {#Sec8}
-------------------------------------

Water-soluble and water-insoluble CGP was extracted using a modified method of Ziegler et al. ([@CR44]). Mycelium was harvested and disrupted as described in a previous section and 1 g (wet weight) was resuspended in 10 ml 20 mM Tris/HCl buffer pH 7.5. The suspension was centrifuged for 20 min at 4,600 g and 4°C. The cell-free extract was separated from the pellet, and water-soluble CGP was extracted from the cell-free extract. The soluble fraction was incubation at 65°C for 20 min and centrifuged for 20 min at 4,600 g at 4°C. The supernatant was incubated overnight with proteinase K after which the proteins were precipitated with ice-cold ethanol, washed with acetone, and air-dried.

Water-insoluble CGP was isolated from the biomass pellet obtained during the isolation of water-soluble CGP. This pellet was resuspended in 0.1 M HCl until the CaCO~3~ was dissipated and the pH of the sample was 1. The sample was centrifuged for 20 min at 4,600 g at 4°C. The supernatant was neutralized with 0.1 M NaOH and re-centrifuged. The pellet was washed twice with demineralized water and dried. At each step, the dry weight of the removed material was gravimetrically determined to calculate the weight percentage of the accumulated CGP. The molecular mass of the CGP was determined by SDS-PAGE analysis using an 11.5% (*w*/*v*) polyacrylamide gel as described by Laemmli ([@CR21]) with 50 μg of dried protein per slot. The protein marker used was a precision plus protein standard from Bio-Rad (Bio-Rad, Hercules, CA). The gels were stained with Coomassie Brilliant Blue R-250. To determine the amino acid composition, the isolated protein was hydrolyzed in 6 M HCl with 1% *w*/*v* of phenol at 110°C for 24 h under nitrogen atmosphere. The individual amino acids were derivatized with OPA-reagent (*o*-phthaldialdehyde) and FMOC (9-fluorenylmethoxycarbonyl chloride) (Sigma-Aldrich, St. Louis, MO). The amino acid analysis was done using the Dionex rapid separation liquid chromatography (RSLC) system (Dionex Corporation, Sunnyvale, CA) with an Acquity UPLC^®^ BEH C18 reversed phase column (Waters, Milford, MA) using an Ultimate 3000 variable wavelength detector (Dionex Corporation, Sunnyvale, CA).

Results {#Sec9}
=======

Transformant stability {#Sec10}
----------------------

The stability of transformants generated in this study for the *pyrF* phenotype was determined with the aid of 5-fluoro-orotic acid (5-FOA) and uracil selection. If the selection marker is lost, *pyrF* transformants are unable to metabolize 5-FOA, thereby preventing cell death, and uracil in the plates would facilitate cell growth. None of the transformants or the wild type were able to grow on the plates containing 5-FOA and uracil. This shows that all generated transformants were stable for the *pyrF* phenotype.

*CphA* expression in *R. oryzae* transformants {#Sec11}
----------------------------------------------

The *cphA*-encoding genes from *Anabaena* sp. strain PCC7120 (*cphA*~7120~) and *Synechocystis* sp. strain PCC6803 (*cphA*~6803~) were selected for expression in *R. oryzae* 99-880 on basis of their close codon usage. The GC difference in the first three bases for *cphA*~7120~ was 3%, 3%, and 13% for *cphA*~6803~, the difference was 2%, 2%, and 2%. To further increase the efficiency of gene translation, codon-optimized genes were designed and cloned by DNA 2.0 (Menlo Park, CA). All the genes were cloned into the *R. oryzae* expression vector pPdcExPyrF (Table [1](#Tab1){ref-type="table"}). It was impossible to obtain a vector containing the codon-optimized gene of *cphA*~6803~, despite the fact that several *E. coli* strains were used as a host for plasmid propagation. The transformation of *R. oryzae* spores with the expression vectors was accomplished by the biolistic transformation method. In total, 40, 14, and 38 transformants were isolated with the unmodified *cphA*~7120~, the codon optimized *cphA*~7120~ and the *cphA*~6803~-encoding genes, respectively (Table [3](#Tab3){ref-type="table"}). The total number of transformants isolated directly after the transformation with the codon-optimized gene was 60, yet many failed to grow or sporulate in the isolation process for single progeny. All generated transformants were grown in liquid RZ medium for 72 h after which the mycelium was harvested for RNA extraction and protein analysis. The transformants were screened with quantitative real-time PCR (qPCR) for the presence and the amount of the specific *cphA* transcript. Not all isolated transformants expressed the *cphA*-encoding 8 out of 40 for cphA7120, 1 out of 14 for codon optimized *cphA*~7120~, and 14 out of 38 for *cphA*~6803~ (Table [3](#Tab3){ref-type="table"}). The transcript levels for the *cphA*~7120~-encoding genes represented 0.01% to 0.4% of the PDC transcript. For the transformants, expressing the *cphA*~6803~-encoding gene was much higher, ranging from 0.8% to 39.5% of the PDC transcript. In the wild-type strain, the apparent transcript level of the *cphA*-encoding genes represented 1‰ of the PDC gene; this was considered to be an a-specific transcript.Table 3Number of transformants generated and tested positive at various stages in the experimentCod opt; codon optimized*cphA* variantNumber of generated transformantsTransformants with transcript levelTransformants with CphA activityTransformants with CGP accumulation*cphA*~7120~40800*cphA*~7120~ cod opt14100*cphA*~6803~381121

*CphA* activity in *R. oryzae* transformants {#Sec12}
--------------------------------------------

Transformants in which a *cphA* transcript was detected were further analyzed for CphA activity as determined with the scintillation assay. In two transformants, both expressing the *cphA*~6803~ gene, specific enzyme activity was detected. These transformants were named transformant *cphA*~6803~\# 1and transformant *cphA*~6803~\#2. Both transformants had a specific enzyme activity of 1.5 mU/mg proteins, which was much higher than the wild-type in which an activity of 0.27 mU/mg protein was measured (Table [4](#Tab4){ref-type="table"}). To determine if protease activity was the cause of the low specific enzyme activity, a broad-spectrum protease inhibitor cocktail was added to fresh cell-free extract. This did not lead to an increase in the enzyme activity (data not shown).Table 4Specific activities of cell-free extractStrain and transformantsRelative *cphA* transcriptMean DPM ± SDMean CphA sp. act. (mU/mg) ± SDPercent dry weight water-soluble CGP/insoluble CGPWild-type1.42E-05448 ± 3170.27 ± 0.0660/0*cphA*~6803~\#11.2E + 011,838 ± 4361.5 ± 0.360.5/0*cphA*~6803~\#22.5E + 012,220 ± 5041.5 ± 0.350/0All assays were performed in triplicate. Transcript levels are relative to the PDC gene transcript. One unit is defined as the amount of [l]{.smallcaps}-arginine incorporated in nanomole in 1 min per milligram protein (Ziegler et al. [@CR45])*SD* standard deviation

Determination of the presence of CGP {#Sec13}
------------------------------------

CGP was extracted using the protocols for water-soluble and insoluble CGP. Only in transformant *cphA*~6803~\#1 water-soluble and insoluble CGP was detected by SDS-PAGE analysis (Fig. [2](#Fig2){ref-type="fig"}). This transformant accumulated mainly water-soluble CGP to a maximal amount of 0.5% dry weight of the biomass (Table [4](#Tab4){ref-type="table"}). The water-insoluble CGP was accumulated in such small quantities that it was impossible to accurately determine the dry weight percentage. The protein fractions were analyzed on SDS-PAGE gel. Both forms of CGP appeared to be poly-disperse in molecular mass. The molecular mass of the water-insoluble CGP ranged from 25 to 37 kDa, whereas the molecular mass of the water-soluble CGP ranged between 10 and 20 kDa (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Water-soluble and insoluble CGP extracted from *R. oryzae* transformants SDS-PAGE analysis of the CGP accumulated in transformants of *R. oryzae* M 16 expressing *cphA*-encoding gene from *Synechocystis* sp. Strain PCC6803. **a** The water-soluble CGP samples. **b** The water-insoluble samples. Per *lane*, 50 μg sample of each of the different transformants was loaded. **a***Lane 1*; 20 μg CGP from *S. cerevisiae* G175 expressing the *cphA*-encoding gene from *Synechocystis* sp. strain PCC6308 (Bröker et al. [@CR6]), *lane 2*; *R. oryzae* 99-880, *lane 3*; *R.* oryzae M16 transformant *cphA*~*6803*~ \#2, 4; *R. oryzae* transformant M16 *cphA*~*6803*~ \#1; 5, protein marker. **b***Lane 1*; 20 μg CGP from *S. cerevisiae* G175 expressing the *cphA*-encoding gene from *Synechocystis* sp. strain PCC6308 (Bröker et al. [@CR6]); *lane 2*; protein marker, *lane 3*; *R. oryzae* 99-880, *lane 4*; *R. oryzae* M16 expressing *cphA*~6803~ \#1

Amino acid composition of CGP {#Sec14}
-----------------------------

The amino acid composition of the isolated CGP was determined by rapid separation liquid chromatography (RSLC). The samples were first hydrolyzed by acid hydrolysis, and as a result, it was not possible to discriminate between aspartic acid and asparagine, nor between glutamic acid and glutamine. The amino acid composition of the water-soluble CGP comprised of equimolar amounts of arginine and aspartic acid/asparagine. These fractions represented 70.4 mol% of the total protein fraction. The remainder of the sample consisted primarily of leucine, glycine, serine, and lysine, with trace amounts of other amino acids. A sample from the wild-type strain extracted by the same method was also analyzed as a reference sample. In this sample, the combined fractions of aspartic acid/asparagine and arginine represented only 16.4 mol% of the total protein present in the sample. The most abundant amino acid fractions were glutamic acid/glutamine, aspartic acid/asparagine and alanine representing 11.4, 11.2, and 10.8 mol%, respectively. Lysine represented 7.2 mol% of the protein fraction in the wild-type sample and only 5.7 mol% in the CGP sample. The amino acid composition of the water-insoluble CGP was not accurately determined due to the low CGP content in the sample.

Discussion {#Sec15}
==========

CGP production in *R. oryzae* {#Sec16}
-----------------------------

The goal of this study was to produce the polypeptide CGP in the filamentous fungus *R. oryzae*. The transcript levels of the different *cphA-*encoding genes varied strongly in the transformants and in only two transformants expressing *cphA*~6803~ was specific enzyme activity detected. The specific activity of CphA in the two transformants was 1.5 mU/mg protein. This is about 1,000 times lower than described for other eukaryotic microorganisms. In *S. cerevisiae* (Bröker et al. [@CR6]) and *P. pastoris* (Bröker et al. [@CR7]) both expressing *cphA*~6308~, the CphA activity was 0.91 and 2.01 U/mg, respectively. In addition, no correlation was detected between transcript levels and the measured enzyme activity for the *R. oryzae* transformants. This in contrast to the results described in a study by Mertens et al. ([@CR25]) with *R. oryzae* NRRL395 using the same promoter. Here, a clear correlation was observed between transcript levels and Green Fluorescence Protein (GFP) accumulation. Furthermore, CGP only accumulated in one of the two transformants which displayed enzyme activity.

There are several possible explanations for the low enzyme activity and CGP accumulation in the *cphA* transformants of *R. oryzae*. One option is a putative instability of the introduced construct. Kroll et al. ([@CR20]) reported a much lower CGP production by engineered *E. coli* cells grown on mineral medium compared to those grown in complex media. It was hypothesized that this was due to the instability of the introduced plasmid. Apparently, the production of CGP in mineral medium, also applied in our study, is a strong metabolic burden resulting in an unstable genotype. A comparable phenomenon was observed in CGP producing transformants of *S. cerevisiae*. Here, a loss in enzyme activity and CGP accumulation occurred in transformants after several cultivation rounds, whereas the gene itself remained present in the cells (Dr. A. Bröker, personal communication). The isolation of single progeny transformants and biomass generation with *R. oryzae* in this study requires three consecutive sporulation events and are equivalent to many cultivation rounds. A loss comparable to that of *S. cerevisiae*\'s enzyme activity after prolonged cultivation can explain the absence or low amounts of active enzyme and CGP. Another option can be a putative toxicity of the *cphA*-encoding gene products. The putative toxicity can also be a reason why there is a discrepancy between the mRNA levels and enzyme activity. Yet the discrepancy can also be a result of the direct inactivation of the CphA protein by, e.g., proteolytic activity.

Currently, a limited number of heterologous genes were successfully expressed in *R. oryzae*. These are genes coding for GFP (Mertens et al. [@CR25]) and lactate dehydrogenase A from *R. oryzae* NRRL395 in *R. oryzae* in 99-880 (Skory and Ibrahim [@CR37]). These genes are either small or originate from closely related organisms. The *cphA*~6803~-encoding gene from cyanobacteria is phylogenetically more distant and with a size of approximately 3 kbp significantly larger than the previously expressed genes. This demonstrated that larger heterologous genes can also be successfully expressed in *R. oryzae*.
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